Glabridin is a bioactive flavonoid concentrated in the roots of Glycyrrhiza glabra (true licorice). In labs, it shows antioxidant and anti-inflammatory properties, and it can inhibit tyrosinase—the enzyme that drives excess melanin—making it a frequent addition to brightening serums. In nutrition research, glabridin-rich “licorice flavonoid oil” (LFO) has been studied for changes in body fat, lipids, and liver markers. This guide explains what glabridin is, how it works, where it helps most, and how to use it safely in topical and oral forms. You will also find clear dosage ranges, product-selection tips, and who should avoid glabridin. While licorice is familiar, glabridin is not the same as glycyrrhizin (the compound tied to blood-pressure spikes); knowing that difference—and the interaction risks of glabridin itself—helps you use it wisely.
Essential Insights
- May reduce hyperpigmentation by inhibiting tyrosinase and calming inflammation
- Oral licorice flavonoid oil has data for modest visceral fat reduction in trials
- Start topicals at 0.5% glabridin once daily; oral LFO commonly studied at 300–900 mg/day (providing single-digit mg of glabridin)
- Glabridin can affect drug-metabolizing enzymes; review medications for interactions
- Avoid during pregnancy, breastfeeding, and with hormone-sensitive cancers unless a clinician approves
Table of Contents
- What is glabridin?
- What benefits are supported by evidence?
- How to use glabridin correctly
- Dosage and timing: how much and how long?
- Common mistakes and troubleshooting
- Safety, side effects, and who should avoid it
- Research at a glance
What is glabridin?
Glabridin is a prenylated isoflavan found in the lipophilic (oil-soluble) fraction of Glycyrrhiza glabra root. Chemically, it sits in the flavonoid family, which explains its pronounced antioxidant capacity and affinity for cell membranes. Unlike glycyrrhizin—the better-known saponin from licorice that can raise blood pressure via mineralocorticoid effects—glabridin acts through different mechanisms and is typically present in glabridin-standardized extracts or in “licorice flavonoid oil” (LFO), a formulated oil that concentrates hydrophobic polyphenols.
You’ll encounter glabridin in two main contexts:
- Topical skin care: as a brightening and soothing active in serums, creams, and spot correctors. It’s valued for inhibiting tyrosinase (the rate-limiting enzyme in melanin synthesis) and for reducing UV-induced inflammation that worsens hyperpigmentation. Because glabridin is oil-soluble, it fits well in emulsion serums and anhydrous oils.
- Oral nutrition: as LFO capsules or softgels, often standardized to a small percentage of glabridin along with other licorice polyphenols. Trials have explored body-composition changes (especially visceral fat), lipid profiles, and hepatometabolic markers. These products are distinct from deglycyrrhizinated licorice (DGL) chews used for reflux and from whole-root powders.
Pharmacokinetically, glabridin’s oral bioavailability appears limited by first-pass metabolism and glucuronidation, which helps explain why human studies use daily dosing and oil vehicles. In contrast, topical delivery puts glabridin directly at epidermal targets where tyrosinase resides, allowing effective local concentrations at relatively low percentages.
A practical note on names: you may see “Glavonoid®,” a branded licorice polyphenol ingredient used in foods and supplements; it provides a defined daily intake of licorice flavonoids (including glabridin) under certain regulatory approvals. Labels may also list “licorice flavonoid oil” or “licorice polyphenol oil.” For skin care, labels usually state “glabridin” or “licorice extract” with a standardized percentage.
In short, think of glabridin as licorice’s oil-phase, antioxidant workhorse with two distinct application paths—skin brightening topically and metabolic support orally—each with its own best practices, time frames, and safety considerations.
What benefits are supported by evidence?
Hyperpigmentation and skin tone
In cell and animal models, glabridin inhibits tyrosinase activity and interferes with multiple steps of melanogenesis, while dampening inflammatory mediators that can worsen post-inflammatory hyperpigmentation. These dual actions—enzyme inhibition plus anti-inflammatory effects—make it a logical choice for uneven tone, melasma-prone skin, and lingering marks after acne or eczema. In practice, glabridin is often combined with niacinamide, vitamin C derivatives, tranexamic acid, alpha arbutin, or exfoliating acids to address both the pigment trigger and the inflammation that sustains it. Users commonly report a more even tone within 6–8 weeks, with continued improvements through 12 weeks when daily use continues.
Redness, sensitivity, and photo-exposed skin
By modulating NF-κB and related inflammatory pathways, glabridin helps temper redness and discomfort in irritated or UV-exposed skin. Formulators take advantage of its oil solubility to pair glabridin with barrier-support lipids (ceramides, squalane), which can be helpful in routines that include retinoids or chemical exfoliants. The ingredient’s antioxidant behavior also means it scavenges reactive oxygen species generated by UV and pollution, complementing daily sunscreen.
Body composition and metabolic markers (oral LFO)
Randomized, placebo-controlled data with licorice flavonoid oil suggest modest but meaningful reductions in visceral fat area over 8–12 weeks, with some studies noting parallel improvements in waist circumference and serum triglycerides. Mechanistically, LFO appears to up-regulate fatty-acid oxidation pathways and improve hepatic lipid handling. Effects are incremental—expect changes measured in centimeters and imaging-based fat area rather than dramatic weight loss on the scale. Importantly, lifestyle alignment (adequate protein, activity, sleep) strengthens outcomes.
Liver and cardiometabolic support
Preclinical and early human-relevant data indicate glabridin can modulate oxidative stress and inflammatory signaling in the liver, while improving lipid profiles in some settings. This has led to exploratory use of LFO in non-alcoholic fatty-liver risk profiles alongside diet and exercise. As with most polyphenols, benefits accrue gradually and require consistency.
Additional fronts under study
Glabridin’s portfolio includes antimicrobial and neuroprotective signals in preclinical work, and it’s being explored for synergy with other therapies (for example, enhancing chemotherapeutic exposure via enzyme modulation in lab models). These are promising but not yet clinical standards. For everyday consumers, the most evidence-supported use cases remain: (1) topical tone evening and (2) oral LFO for small improvements in visceral fat and lipids when paired with lifestyle strategies.
What results to expect, and when
- Topical: subtle brightening and reduced blotchiness from week 4; clearer, more even tone by weeks 8–12 with daily use and sunscreen.
- Oral LFO: small reductions in visceral fat indices by weeks 8–12; better odds when combined with resistance training or brisk walking.
- Maintenance: topicals can be continued long-term; oral courses are often 8–12 weeks, then reassessed.
Set realistic expectations: glabridin is a supportive active, not a stand-alone cure. Pair it with sun protection, consistent skin care, and—if using oral LFO—a nutrition and activity plan.
How to use glabridin correctly
Topical (brightening and calming)
- Choose a concentration that matches your skin. Many effective formulas use around 0.5% glabridin. Sensitive skin can start every other day for the first week, then increase to daily as tolerated.
- Layer smartly. After cleansing and (optionally) a hydrating toner, apply your glabridin serum, then seal with moisturizer. In daytime, follow with broad-spectrum sunscreen.
- Combine with compatible actives. Niacinamide (2–5%), vitamin C derivatives (e.g., 3-O-ethyl ascorbic acid), azelaic acid, and tranexamic acid pair well. If you use retinoids or exfoliating acids, alternate nights or apply glabridin earlier in the routine to buffer potential irritation.
- Be consistent. Pigmentation pathways respond slowly. Photograph your skin under similar lighting every 3–4 weeks to track progress you might otherwise miss.
Oral (licorice flavonoid oil)
- Understand what’s in the capsule. “LFO” products provide licorice polyphenols in an oil base. Labels often list total LFO milligrams (e.g., 300–900 mg/day in studies) and may note a glabridin percentage in the low single digits. That means a 300 mg LFO serving might deliver only single-digit milligrams of glabridin.
- Timing and meals. Take with food to support absorption and to minimize queasiness. Consistency (daily intake) matters more than exact timing.
- Pair with lifestyle. The best outcomes for visceral fat indices occur with regular activity (e.g., 150 minutes/week moderate cardio plus 2–3 resistance sessions) and adequate dietary protein.
- Cycle and reassess. Consider 8–12 weeks of daily use, then review body-composition measures or waist circumference before deciding on a maintenance plan.
Quality and authenticity checks
- Look for standardization (e.g., stated glabridin content) and independent testing for heavy metals and contaminants.
- Prefer brands that disclose the source species (Glycyrrhiza glabra) and clearly distinguish glabridin-rich extracts from whole-root or glycyrrhizin-heavy products.
- For skincare, opaque or UV-protected packaging helps preserve potency, as polyphenols can degrade with light exposure. Store away from heat and use within the product’s period-after-opening.
Who benefits most
- Topical users concerned with melasma-prone areas, post-acne marks, or mottled tone—especially with darker skin tones that hyperpigment easily.
- Oral LFO users seeking small, supportive changes in visceral fat or liver-related markers as part of a broader program.
When to involve a clinician
- If you take prescription medications (particularly those with narrow therapeutic windows), have cardiovascular, hepatic, or endocrine conditions, or plan use alongside other botanicals or weight-management agents, ask a healthcare professional to review for interactions and appropriateness.
Dosage and timing: how much and how long?
Topical dosing
- A practical, evidence-informed starting point is 0.5% glabridin, applied once daily, increasing to twice daily if well tolerated and if sunscreen is used consistently in daytime.
- Sensitive or compromised skin (eczema-prone, retinoid newbies) can begin with every-other-day application for 1–2 weeks before stepping up.
- Expect visible tone evening by week 8; maintain results with ongoing daily use plus sun protection.
Oral LFO dosing
- Clinical trials commonly use 300–900 mg/day of licorice flavonoid oil for 8–12 weeks. Because LFO contains a low percentage of glabridin (often around the low single digits), the actual glabridin intake is typically in the single- to low-tens of milligrams per day.
- Regulatory opinions on certain branded licorice polyphenol ingredients (used in foods/supplements) recommend defined daily intakes; always follow your product’s labeled maximum daily amount.
- Start low (300 mg/day LFO) for two weeks to assess tolerance, then consider 600 mg/day if your clinician agrees and your product label allows. Higher intakes belong under clinical guidance.
Timing and stacking
- With meals supports absorption and may reduce stomach upset.
- If stacking with omega-3s, fiber, or green-tea catechins, separate doses by 1–2 hours to avoid competitive absorption or binding in the gut.
- For fitness goals, take LFO consistently; combine with progressive resistance training for better body-composition outcomes.
Special populations and adjustments
- Older adults: start at the lower end of dosing ranges and titrate slowly, as polyphenol metabolism and concomitant medications vary.
- Liver or kidney conditions: glabridin is metabolized and cleared via pathways that may be impacted; involve your clinician before use.
- Hormone-sensitive conditions: because glabridin has weak estrogenic signals in lab models, those with current or past hormone-sensitive cancers should avoid use unless their oncology team approves.
How long to use
- Topical: continue indefinitely if helpful and well tolerated; consider tapering to once daily or a few nights per week for maintenance after achieving your goal.
- Oral: reassess after 8–12 weeks. Continue if objective measures (waist, imaging, lipids) improved and no interactions or adverse effects occurred.
What not to do
- Don’t exceed your product’s maximum daily amount.
- Don’t rely on glabridin to offset poor sleep, low protein intake, or inactivity; it’s a complement, not a substitute.
Summarizing numbers you can use: Topical 0.5% once daily (up to twice if tolerated); Oral 300–900 mg/day LFO for 8–12 weeks, glabridin content in the single-digit mg range, taken with meals and lifestyle support.
Common mistakes and troubleshooting
Using glabridin without sunscreen
Tyrosinase-targeting actives work best when UV exposure is minimized. Skipping sunscreen undermines progress and can deepen uneven tone. Use a broad-spectrum SPF 30+ daily and reapply during prolonged exposure.
Expecting instant fading
Melanin pathways move slowly. Give topical glabridin 8–12 weeks before judging. Track progress with consistent photos and lighting. If you plateau, add a complementary active (e.g., tranexamic acid or azelaic acid) rather than abandoning the routine.
Over-layering potent actives
Stacking strong acids, retinoids, vitamin C, and multiple brighteners in the same session may irritate and paradoxically trigger post-inflammatory hyperpigmentation. Alternate nights or split your actives (vitamin C in the morning; glabridin at night) and use a ceramide-rich moisturizer.
Mismatching oral expectations
LFO isn’t a quick weight-loss pill. Its best results are modest visceral-fat changes measured over weeks, especially with exercise. If you don’t adjust diet or activity, you may see little change.
Ignoring medication interactions
Glabridin can interact with drug-metabolizing enzymes, affecting levels of certain medications. If you take anticoagulants, antiepileptics, immunosuppressants, or other narrow-therapeutic-index drugs, get a clinician’s review before starting LFO.
Buying non-standardized products
Products that don’t state their glabridin content or licorice species introduce uncertainty. Choose brands with transparent sourcing and third-party testing.
Troubleshooting quick guide
- Redness or stinging (topical): pause for 2–3 nights, reintroduce every other night, sandwich between moisturizer layers, and limit other irritants.
- No brightening by week 8: confirm sunscreen adherence, add a gentle exfoliant 1–2×/week, or pair with niacinamide or tranexamic acid.
- Stomach upset (oral): take with larger meals or split the daily dose; if persistent, lower the dose or discontinue.
- Plateau after early wins: shift to a maintenance schedule (topical once daily; oral every other day under guidance), and revisit basics—sleep, protein, fiber, resistance training.
When in doubt, simplify: fewer, well-chosen steps performed consistently beat a crowded, irritating routine.
Safety, side effects, and who should avoid it
General tolerance
Topical glabridin is typically well tolerated. Mild, transient tingling on first use can occur, especially if combined with exfoliants or retinoids. True allergic responses are rare but possible with any botanical; discontinue if you develop persistent redness, swelling, or itch.
Oral considerations
Glabridin and related licorice flavonoids may influence cytochrome P450 enzymes and other drug-handling pathways. Depending on the medication, this can raise or lower drug levels. Practical steps: list your medications, check for interactions, and start low. Because glabridin is oil-soluble and metabolized in the liver and intestine (with notable first-pass effects), those with liver disease should use only with medical supervision.
Blood pressure and glycyrrhizin
The worrisome licorice compound for blood pressure is glycyrrhizin, not glabridin. Many glabridin-rich ingredients (like LFO or certain branded extracts) are formulated to be low in glycyrrhizin, but products vary. If you have hypertension, confirm glycyrrhizin content with the manufacturer and monitor your pressure—especially during the first 2–4 weeks of oral use.
Hormone-sensitive conditions
Glabridin shows weak estrogen-like signals in preclinical work. Out of caution, those with estrogen- or progesterone-sensitive cancers, endometriosis, or undiagnosed abnormal bleeding should avoid glabridin unless their specialist approves.
Pregnancy and breastfeeding
Avoid oral and topical glabridin during pregnancy and lactation due to limited safety data and theoretical hormonal/enzymatic considerations.
Surgery and anesthesia
Because of potential enzyme interactions, stop oral LFO at least 2 weeks before elective procedures, unless your surgical team advises otherwise.
Stop and seek care if you notice
- Persistent headaches, marked dizziness, or swelling (especially if blood pressure runs high)
- Dark urine, jaundice, or unusual fatigue (possible liver-related issues)
- Easy bruising or unexpected bleeding when on anticoagulants
Bottom line on safety
Topical use is generally low-risk with sunscreen and gradual introduction. Oral use requires more care: confirm product standardization, review medications for interactions, and respect labeled maximum daily amounts.
Research at a glance
Mechanisms
Glabridin exhibits robust antioxidant behavior and anti-inflammatory signaling (e.g., down-modulating NF-κB), and it inhibits tyrosinase, aligning with its skin-brightening role. In metabolic contexts, it may enhance fatty-acid oxidation and support hepatic lipid handling. Pharmacokinetically, oral bioavailability is limited by first-pass metabolism and glucuronidation, motivating oil-based delivery and daily dosing.
Clinical signals
- Skin: Evidence for human use comes mainly from formulations leveraging glabridin within multi-ingredient brightening serums, supported by mechanistic and preclinical data specific to glabridin’s tyrosinase inhibition and anti-inflammatory activity. Consistent daily application over 8–12 weeks shows the best outcomes, especially when paired with rigorous sun protection.
- Body composition: Randomized, placebo-controlled data in overweight adults show modest reductions in visceral fat with oral LFO over 8–12 weeks, with some improvements in triglycerides. Magnitudes are small but relevant to metabolic risk when combined with lifestyle measures.
- Liver and cardiometabolic: Early human-relevant and preclinical findings suggest improvements in oxidative stress and inflammatory markers; more large, multicenter trials are needed.
Safety and interactions
Updated reviews and human interaction studies note that licorice constituents, including glabridin, can interact with drug-metabolizing enzymes. The clinical significance varies by product, dose, and medication. Regulatory evaluations of specific branded licorice polyphenols have set upper intake levels for use in foods or supplements; follow labeled limits and medical advice.
Evidence quality snapshot
- Strong mechanistic base (multiple lab and animal models)
- Moderate clinical evidence for visceral fat change with LFO
- Emerging but practical topical evidence for brightening, reinforced by mechanism and formulation science
- Interaction potential requires patient-specific judgment
For consumers, that translates to sensible optimism: glabridin can be a useful adjunct for tone evening (topical) and for incremental metabolic support (oral) when integrated into a broader plan and used with appropriate safeguards.
References
- Review on the Diverse Biological Effects of Glabridin 2023 (Review)
- Comprehensive Evaluation of Metabolism and the Contribution of the Hepatic First-Pass Effect in the Bioavailability of Glabridin in Rats 2023
- New Herbal Biomedicines for the Topical Treatment of Hyperpigmentation 2020 (Review)
- Licorice flavonoid oil reduces total body fat and visceral fat in overweight subjects: a randomized, double-blind, placebo-controlled study 2009 (RCT)
- Scientific Opinion on the safety of ‘Glavonoid®’, an extract derived from the roots of or rootstock of Glycyrrhiza glabra L., as a novel food ingredient 2011 (Guideline)
Medical Disclaimer
This information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Always speak with a qualified healthcare professional before starting, stopping, or combining supplements—especially if you are pregnant or breastfeeding, have a medical condition, or take prescription medications. If you experience adverse effects, stop use and seek medical care.
If you found this guide useful, consider sharing it on Facebook, X (formerly Twitter), or your favorite platform, and follow us for future updates. Your support helps us keep creating clear, evidence-based resources. Thank you.
